OmniaBio
A QC Data Reviewer Associate at CCRM ensures quality control in regenerative medicine, focusing on data accuracy, compliance with GMP and GDP standards, and supporting the development of cell and gene therapies.
OmniaBio is a contract development and manufacturing organization (CDMO) focused exclusively on cell and gene therapies. The company offers specialized, efficient services to advance programs from preclinical development through commercial‑scale manufacturing. OmniaBio positions itself as a partner that brings maturity to the cell and gene therapy sector by delivering scalable processes, development and manufacturing expertise, and regulatory‑aware solutions to accelerate translation and commercialization.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for OmniaBio.
OmniaBio didn’t post a salary, so this is our estimate from similar listings.